Needle-Free Injectors Market Detail Analysis of Current and Future Projection 2022 to 2032

According to a recent FMI analysis, the worldwide Needle-Free Injectors Market demand would grow at a 12% CAGR from 2022 to 2032. The market is anticipated to be valued at US$ 42.79 billion by the end of the assessment period. The major driver for the needle-free injector market is faster drug delivery. The growing need for Needle-Free Injectors is being driven by increased demand in the healthcare industry as well as expansion in cosmetic procedures.

From 2017 to 2021, the industry grew significantly, with a value CAGR of 8% and a total value of US$ 12.3 billion. The usage of technologically improved spring-loaded jet injectors is boosting market expansion. Furthermore, official approvals to maximise the usage of Needle-Free Injectors are increasing demand for the same.

Geographically, the United States is the leading contributor to the Needle-Free Injectors market. This is due to the region's increasing prevalence of chronic diseases. The existence of healthcare sectors in Germany, Japan, and China is further hastening the adoption of Needle-Free Injectors. The growing preference for minimally invasive operations will drive up sales of Needle-Free Injectors in the coming years.

Market Competition

Key players in the Needle-Free Injectors market are Gerresheimer AG, Pfizer Inc., Antares Pharma, CSL Limited (Seqirus UK Limited), Crossject, Portal Instruments, Ferring Pharmaceuticals, PharmaJet Inc., PenJet Corporation

Get More Details@ https://www.futuremarketinsights.com/reports/needle-free-injectors-market

Key Segments Profiled In The Needle-Free Injectors Market Industry Survey

Needle-Free Injectors Market by Load:

  • Needle-Free Injectors by Liquid Injections
  • Needle-Free Injectors by Powder Injections
  • Needle-Free Injectors by Projectile Injections

Needle-Free Injectors Market by Technology:

  • Needle-Free Injectors by Spring-loaded jet injector
  • Needle-Free Injectors by Battery-powered jet injector
  • Needle-Free Injectors by Gas-powered jet injector

Needle-Free Injectors Market by Delivery Site:

  • Needle-Free Injectors by Intra dermal injectors
  • Needle-Free Injectors by Intramuscular injectors
  • Needle-Free Injectors by Subcutaneous injectors

Needle-Free Injectors Market by Application:

  • Needle-Free Injectors by Drug Delivery
  • Needle-Free Injectors by Vaccines
  • Needle-Free Injectors by Cosmetic
  • Needle-Free Injectors by Others

Needle-Free Injectors Market by End User:

  • Needle-Free Injectors by Home Care Settings
  • Needle-Free Injectors by Long Term Care Centers

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more